牛磺酸代谢通过促进浆细胞样树突状细胞功能加重狼疮进展
该研究通过质谱代谢组学发现SLE患者血清牛磺酸水平高于健康对照和类风湿关节炎患者,且与疾病活动度和I型干扰素特征基因表达正相关。牛磺酸通过NCF1依赖方式降低pDC活性氧水平、促进IRF7磷酸化,增强I型干扰素产生,并在小鼠中加重肾炎。靶向抑制牛磺酸或限制牛磺酸饮食具有治疗潜力。
要点
- SLE患者血清牛磺酸升高,与疾病活动度和I型干扰素特征基因表达正相关。
- 牛磺酸通过NCF1依赖方式降低pDC活性氧、促进IRF7磷酸化,增强I型干扰素产生。
- 牛磺酸补充在小鼠中加重狼疮肾炎,靶向抑制牛磺酸或限制饮食有治疗潜力。
核心结论
- 牛磺酸代谢通过增强pDC介导的I型干扰素产生参与SLE发病,靶向抑制牛磺酸或限制牛磺酸饮食具有治疗潜力。
研究设计与样本
- 对SLE患者和健康对照血清进行质谱代谢组学分析,并在人及小鼠pDC中探索SLE相关代谢物对I型干扰素产生的影响。
- 采用野生型和Ncf1-/-小鼠的pDC通过流式细胞术检测活性氧水平,通过RNA测序和免疫印迹研究机制。
- 在B6.Cg-Sle1NZM2410/Aeg Yaa/DcrJ小鼠中系统分析SLE相关代谢物的体内效应。
主要发现
- SLE患者血清牛磺酸高于健康对照(P < 0.001)和类风湿关节炎患者(P < 0.001),牛磺酸含量与疾病活动度和干扰素特征基因表达正相关。
- 添加牛磺酸以中性粒细胞胞浆因子1依赖方式降低pDC活性氧水平,促进干扰素调节因子7磷酸化,增强I型干扰素产生。
- 补充牛磺酸促进I型干扰素诱导基因表达、激活淋巴细胞、增加自身抗体和蛋白尿,导致更严重的肾炎。
临床怎么用
- SLE患者血清牛磺酸水平可能作为疾病活动度和I型干扰素通路的潜在生物标志物。
- 靶向抑制牛磺酸或实施限制牛磺酸饮食可能成为SLE的治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Type I interferons (IFNs) are critical in the development of systemic lupus erythematosus (SLE). Metabolic abnormalities cause dysregulation of multiple immune cells, but the metabolic regulation of type I IFN production is not well clarified in SLE. We undertook this study to define amino acid metabolism features in SLE and to explore the function of disease-relevant metabolites in the control of plasmacytoid dendritic cell (pDC)-mediated type I IFN production and the progression of SLE. METHODS: Metabolomic profiling of the serum from SLE patients and healthy controls was performed by mass spectrometry. The effects of SLE-related metabolites on type I IFN production were explored in human and mouse pDCs. The reactive oxygen species (ROS) levels of pDCs from wild-type and Ncf1-/- mice were measured by flow cytometry. Mechanisms were investigated by RNA sequencing and immunoblotting. In vivo effects of SLE-relevant metabolites were systemically analyzed in B6.Cg-Sle1NZM2410/Aeg Yaa/DcrJ mice. RESULTS: Taurine was higher in the serum from SLE patients compared to healthy controls (P < 0.001) and rheumatoid arthritis patients (P < 0.001). Taurine content was positively correlated with disease activity and the expression of IFN signature genes. The addition of taurine facilitated IFN regulatory factor 7 phosphorylation and enhanced type I IFN production by reducing the ROS levels in pDCs in a neutrophil cytosolic factor 1-dependent manner. Taurine supplementation promoted expression of type I IFN-induced genes, activated lymphocytes, and increased autoantibodies and proteinuria, leading to more serious nephritis. CONCLUSION: Taurine metabolism is involved in the development of SLE by enhancing pDC-mediated type I IFN production. Targeted inhibition of taurine or implementation of a taurine-restricted diet has therapeutic potential in SLE.
引用
- Li J, Ding H, Meng Y, et al. Taurine Metabolism Aggravates the Progression of Lupus by Promoting the Function of Plasmacytoid Dendritic Cells. Arthritis Rheumatol. 2020. PMID: 32608557. doi:10.1002/art.41419
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。